Showing results (351-360 of 447) with videos related to

Sort By:
Pageof 45
JCO Precision Oncology|March 12, 2026
Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL StudyAndrea Boutros, Matteo S Carlino, Raja Chaganti, et al.
Disease Models & Mechanisms|May 13, 2018
A comprehensive study of calcific aortic stenosis: from rabbit to human samplesLaura Mourino-Alvarez, Montserrat Baldan-Martin, Tamara Sastre-Oliva, et al.
Journal of Clinical Microbiology|September 1, 2023
Development of a rapid lateral flow assay for detection of anti-coccidioidal antibodiesFrancisca J Grill, Sergei Svarovsky, Maria Gonzalez-Moa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 15, 2024
Access to melanoma drugs in Spain: a cross-sectional surveyMaria Gonzalez-Cao, Teresa Puertolas, Jose Luis Manzano, et al.
Frontiers in Immunology|August 1, 2022
Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 VaccinationMarta Sisteré-Oró, Diana D J Wortmann, Naína Andrade, et al.
The Journal of Infectious Diseases|March 11, 2021
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2Ludivine Grzelak, Aurélie Velay, Yoann Madec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Influence of biospecimen variables on proteomic biomarkers in breast cancerFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2023
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 TherapySarah A Weiss, Mario Sznol, Montaser Shaheen, et al.
Pageof 45